Cargando…
Effects of Entecavir on Hepatitis B Virus Covalently Closed Circular DNA in Hepatitis B e Antigen-Positive Patients with Hepatitis B
The aim of this study was to assess the effect of 48-week entecavir therapy on serum and intrahepatic hepatitis B virus, covalently closed circular DNA (HBV cccDNA) levels in hepatitis B e antigen (HBeAg)-positive patients. A total of 120 patients with HBeAg-positive chronic hepatitis were treated w...
Autores principales: | Shi, Ming, Sun, Wan-Li, Hua, Yan-Yan, Han, Bo, Shi, Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315599/ https://www.ncbi.nlm.nih.gov/pubmed/25647607 http://dx.doi.org/10.1371/journal.pone.0117741 |
Ejemplares similares
-
Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B
por: Chen, En-Qiang, et al.
Publicado: (2017) -
Research progress in hepatitis B virus covalently closed circular DNA
por: Zhang, Xiaodong, et al.
Publicado: (2022) -
Approaches to quantifying hepatitis B virus covalently closed circular DNA
por: Zhang, Henrik, et al.
Publicado: (2022) -
Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B
por: Liem, Kin Seng, et al.
Publicado: (2019) -
Seroconversion of Hepatitis B Virus Surface Antigen in Chronic Hepatitis B Child Treated with Entecavir
por: Li, Dong, et al.
Publicado: (2012)